Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction

In heart failure with preserved ejection fraction (HFpEF), natriuretic peptide (NP) levels are frequently lower. In several trials, the outcome differed between patients with low and high NP levels. This suggests that NP could be used to identify distinct stages of left ventricular (LV) remodeling a...

Full description

Bibliographic Details
Main Authors: Elisa Dal Canto, Marielle Scheffer, Kirsten Kortekaas, Annet Driessen-Waaijer, Walter J. Paulus, Loek van Heerebeek
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/3/867
_version_ 1797613338266435584
author Elisa Dal Canto
Marielle Scheffer
Kirsten Kortekaas
Annet Driessen-Waaijer
Walter J. Paulus
Loek van Heerebeek
author_facet Elisa Dal Canto
Marielle Scheffer
Kirsten Kortekaas
Annet Driessen-Waaijer
Walter J. Paulus
Loek van Heerebeek
author_sort Elisa Dal Canto
collection DOAJ
description In heart failure with preserved ejection fraction (HFpEF), natriuretic peptide (NP) levels are frequently lower. In several trials, the outcome differed between patients with low and high NP levels. This suggests that NP could be used to identify distinct stages of left ventricular (LV) remodeling and myocardial tissue composition. This study investigated cardiac remodeling/dysfunction and myocardial tissue characteristics assessed by echocardiography and cardiac magnetic resonance (CMR) in HFpEF patients in relation to NP levels. Clinical and echocardiographic data of 152 HFpEF patients were derived from outpatient visits. A total of 71 HFpEF patients underwent CMR-derived T1-mapping. Multivariable regression analyses were performed to examine the association of NT-proBNP categories (</> median) and NT-proBNP as continuous variable with echocardiography and CMR-derived T1-mapping. Mean age was 71 ± 9, 93% of patients were women and median NT-proBNP was 195 pg/mL, with 35% of patients below the diagnostic cut-off value (<125 pg/mL). Patients with high NT-proBNP had comparable LV systolic function and LV relaxation but significantly worse LV stiffness and left atrial function compared with patients with low NT-proBNP. Higher NT-proBNP was significantly associated with higher LV stiffness and extracellular volume fraction (ECV) (β = 1.82, 95% CI: 0.19;3.44, <i>p</i> = 0.029). Higher NT-proBNP levels identify HFpEF patients with worse LV stiffness because of more severe myocardial extracellular matrix remodeling, representing an advanced stage of HFpEF.
first_indexed 2024-03-11T06:53:27Z
format Article
id doaj.art-4ab2d040c48b4fadbec490fcf472d749
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-11T06:53:27Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-4ab2d040c48b4fadbec490fcf472d7492023-11-17T09:46:47ZengMDPI AGBiomedicines2227-90592023-03-0111386710.3390/biomedicines11030867Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection FractionElisa Dal Canto0Marielle Scheffer1Kirsten Kortekaas2Annet Driessen-Waaijer3Walter J. Paulus4Loek van Heerebeek5Laboratory of Experimental Cardiology, Division Heart & Lungs, Utrecht University Medical Centre, 3584 CX Utrecht, The NetherlandsDepartment of Cardiology, OLVG, 1091 AC Amsterdam, The NetherlandsDepartment of Cardiology, Leiden University Medical Center, 2333 ZA Leiden, The NetherlandsDepartment of Radiology, OLVG, 1091 AC Amsterdam, The NetherlandsAmsterdam University Medical Centers, 1066 CX Amsterdam, The NetherlandsDepartment of Cardiology, OLVG, 1091 AC Amsterdam, The NetherlandsIn heart failure with preserved ejection fraction (HFpEF), natriuretic peptide (NP) levels are frequently lower. In several trials, the outcome differed between patients with low and high NP levels. This suggests that NP could be used to identify distinct stages of left ventricular (LV) remodeling and myocardial tissue composition. This study investigated cardiac remodeling/dysfunction and myocardial tissue characteristics assessed by echocardiography and cardiac magnetic resonance (CMR) in HFpEF patients in relation to NP levels. Clinical and echocardiographic data of 152 HFpEF patients were derived from outpatient visits. A total of 71 HFpEF patients underwent CMR-derived T1-mapping. Multivariable regression analyses were performed to examine the association of NT-proBNP categories (</> median) and NT-proBNP as continuous variable with echocardiography and CMR-derived T1-mapping. Mean age was 71 ± 9, 93% of patients were women and median NT-proBNP was 195 pg/mL, with 35% of patients below the diagnostic cut-off value (<125 pg/mL). Patients with high NT-proBNP had comparable LV systolic function and LV relaxation but significantly worse LV stiffness and left atrial function compared with patients with low NT-proBNP. Higher NT-proBNP was significantly associated with higher LV stiffness and extracellular volume fraction (ECV) (β = 1.82, 95% CI: 0.19;3.44, <i>p</i> = 0.029). Higher NT-proBNP levels identify HFpEF patients with worse LV stiffness because of more severe myocardial extracellular matrix remodeling, representing an advanced stage of HFpEF.https://www.mdpi.com/2227-9059/11/3/867heart failureheart failure with preserved ejection fractionnatriuretic peptidesechocardiographycardiac magnetic resonancefibrosis
spellingShingle Elisa Dal Canto
Marielle Scheffer
Kirsten Kortekaas
Annet Driessen-Waaijer
Walter J. Paulus
Loek van Heerebeek
Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
Biomedicines
heart failure
heart failure with preserved ejection fraction
natriuretic peptides
echocardiography
cardiac magnetic resonance
fibrosis
title Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
title_full Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
title_fullStr Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
title_full_unstemmed Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
title_short Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
title_sort natriuretic peptide levels and stages of left ventricular dysfunction in heart failure with preserved ejection fraction
topic heart failure
heart failure with preserved ejection fraction
natriuretic peptides
echocardiography
cardiac magnetic resonance
fibrosis
url https://www.mdpi.com/2227-9059/11/3/867
work_keys_str_mv AT elisadalcanto natriureticpeptidelevelsandstagesofleftventriculardysfunctioninheartfailurewithpreservedejectionfraction
AT mariellescheffer natriureticpeptidelevelsandstagesofleftventriculardysfunctioninheartfailurewithpreservedejectionfraction
AT kirstenkortekaas natriureticpeptidelevelsandstagesofleftventriculardysfunctioninheartfailurewithpreservedejectionfraction
AT annetdriessenwaaijer natriureticpeptidelevelsandstagesofleftventriculardysfunctioninheartfailurewithpreservedejectionfraction
AT walterjpaulus natriureticpeptidelevelsandstagesofleftventriculardysfunctioninheartfailurewithpreservedejectionfraction
AT loekvanheerebeek natriureticpeptidelevelsandstagesofleftventriculardysfunctioninheartfailurewithpreservedejectionfraction